Disease Overview:Mammary hypertrophy(MH)
Macromastia, or symptomatic breast hypertrophy, is a medical condition characterized by excessive breast tissue growth that causes physical discomfort—including chronic back, neck, and shoulder pain; skin irritation or intertrigo; postural abnormalities; and functional impairment in daily activities. Unlike physiological breast enlargement, macromastia often leads to significant psychosocial distress, reduced quality of life, and limitations in exercise or employment. Diagnosis involves clinical evaluation, anthropometric measurements (e.g., breast weight estimation), and exclusion of endocrine or neoplastic causes. Surgical reduction mammoplasty remains the gold-standard intervention, aiming to alleviate symptoms while preserving nipple-areolar complex viability, sensation, and aesthetic symmetry. Procedures typically employ techniques such as the inferior pedicle or vertical scar approaches, with careful attention to vascular supply and long-term contour stability.
China offers distinct advantages for international patients seeking macromastia correction. Leading tertiary hospitals—many accredited by JCI or ISO—employ board-certified plastic surgeons with extensive experience in complex breast reductions, supported by advanced intraoperative imaging, 3D preoperative simulation, and minimally invasive suture technologies. Clinical outcomes reflect high patient satisfaction rates (>92% in published cohorts) and low complication incidence (<5% for major adverse events). Crucially, treatment costs in China are typically 40–60% lower than in the US, UK, or South Korea, without compromising safety or efficacy. As a dedicated medical tourism agency, we facilitate seamless access: verifying surgeon credentials, coordinating hospital admissions at partner institutions, providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and accommodation to postoperative follow-up coordination and multilingual care navigation.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Macromastia (Breast Reduction)
Non-Surgical / Conservative Management
*Indicated for mild symptoms, adolescents awaiting skeletal maturity, or surgical contraindications.*
- •Medical Therapy (off-label): Tamoxifen 10 mg/day × 3–6 months (limited evidence; requires oncology consultation)
- Baseline mammogram + breast ultrasound: $85–$120 - Liver function tests (ALT/AST), CBC, lipid panel: $35–$50 - Monthly monitoring (LFTs + clinical exam): $25/session × 6 visits = $150
- •Supportive Care: Custom-fitted medical-grade bras (e.g., Anita, Trulife)
Surgical Intervention (Plastic & Reconstructive Surgery Department)
*Eligibility: BMI ≤ 32, stable weight ≥6 months, documented functional impairment (back/neck pain, intertrigo, bra strap grooving), age ≥18 (or ≥16 with parental consent + Tanner V maturity).*
- •Standard Reduction Mammoplasty (Wise-pattern/vertical scar)
- Procedure fee (including anesthesia, OR time, surgeon, assistant, nursing): $2,800–$4,100 - Hospital stay (3–5 days, Grade 3A ward): $420–$750 - Post-op compression garment + follow-up (3 visits): $110–$160 - *Total range:* $3,520–$5,270
- •Liposuction-Only Reduction (for predominantly fatty breasts, <500 g reduction per side)
- Procedure fee: $1,900–$2,700 - Day-surgery facility fee: $380–$520 - *Total range:* $2,470–$3,480
Special/Complex Cases
- •Massive Breast Reduction (>1,000 g/side) with Free-Nipple Grafting: Requires microsurgical expertise
- Procedure fee: $5,200–$7,400 - ICU monitoring (1 night): $680–$950 - *Total range:* $6,200–$8,800
- •Revision Surgery (symmetry correction, scar revision):
Quick Selection Guide
- •Adolescent (<18), mild discomfort: Start with custom bra + physical therapy ($180–$320); defer surgery until growth cessation.
- •Adult, moderate symptoms (500–800 g/side), budget-conscious ($2,500–$4,000): Liposuction-only reduction if fatty composition confirmed on ultrasound.
- •Adult, severe functional impairment (>800 g/side), comorbidities (mild hypertension, controlled diabetes): Standard Wise-pattern reduction—preop workup ensures safety; total ~$4,000 optimal value.
- •Massive macromastia (>1,200 g/side) or prior failed surgery: Refer to tertiary 3A center with microsurgery capability; budget $6,200–$8,800.
- •BMI 30–32 or borderline cardiac risk: Require cardiology clearance ($110) and extended preop testing ($260 extra); standard reduction remains first-line.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Mammary hypertrophy Medical Vacation Packages
Curated transparent all-inclusive packages combining Mammary hypertrophy treatment with China top medical destinations: